Peer Review History
| Original SubmissionJune 3, 2023 |
|---|
|
PONE-D-23-15750Estimated standard values of aerobic capacity according to sex and age in a Japanese population: a scoping reviewPLOS ONE Dear Dr. Miyachi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 27 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yosuke Yamada Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: "YES-This work was supported by the National Research and Development Agency (JST), SPRING (Grant Number JPMJSP2128 to Hiroshi Akiyama) and Practical Research Project for Lifestyle-related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Ministry of Health, Labour and Welfare (Grant Number 21FA1004 and 22FA1004 to Motohiko Miyachi)." Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please expand the acronym “JST” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments The authors performed a meta-analysis to estimate the standard values of VO2peak and AT in the Japanese and other populations stratified by sex and age. The theme of the present study is potentially important. Overall, the statistical analyses and data reporting are appropriate. However, unfortunately the manuscript is not well written. This reviewer has a number of comments to improve the quality of the manuscript. Specific comments Page 2, line 29: The words “VO2peak/kg and AT/kg in other populations” suddenly appeared in the latter part of Abstract. The authors should explain beforehand on the aerobic capacity in the other population in the background, purpose, and methods sections. Page 2, lines 31-32: Readers may misunderstand the conclusion sentence. Some readers may think that the decline in the aerobic capacity is lower (or smaller) in Japanese population than the other population when they read only abstract. Please revise the sentence to prevent the potential readers’ confusion. Page 3, lines 50-55: To the reviewer’s understanding, epidemiological evidence regarding the association between aerobic capacity and disease risk or mortality risk is absolutely necessary to establish a reference value of aerobic capacity. This reviewer cannot understand the reason why the standard value of the aerobic capacity is absolutely needed to establish the reference value of aerobic capacity. Please explain the reason more clearly and concretely. Page 4, lines 60-68: The reviewer could not clearly understand the rationales of the primary and secondary aims of the present study. It is even unclear that the authors are trying to explain on the primary or secondary aims in the first paragraph of page 4. The authors should clearly mention the rationales of the primary and secondary aims in this paragraph. The authors should focus on mentioning only the purpose of the present study in the last paragraph of the Introduction section. Page 4, line 71: General readers who are not familiar with meta-analysis may have no idea about the terms “scoping review” as well as “grey literature search”, or “umbrella review”. Please explain more courteously on them in the Materials and methods section or other appropriate sections. Page 4, lines: 60-61: The sentence is poorly written, and needs to be revised. Page 5, lines 94-101: VO2max in the selected articles is directly measured by expired gas during maximal exercise test, or it is indirectly estimated by heart rate response during submaximal exercise test (e.g., using an equation of estimated maximum heart rate 220-age)? It is not clearly written whether the directly or indirectly measured VO2max or both are included (as VO2peak) in the present meta-analysis. Page 6, 102-110: Are these criteria are the criteria for Japanese population or other population or both? The authors performed a meta-analysis of other populations than Japanese population as a secondary aim (one of the major aims of the present study), but they mentioned “studies not in Japanese” as a criterion (line 106). Please be explicit not only about the eligibility criteria, but also the search strategy, study selection, data analysis for each of the Japanese population analysis and other population analysis. Page 6, lines 109-110: The sentence is poorly written, and needs to be revised. Page 6, lines 113-115: There is no description on the roles of the primary and secondary screening. There is also no explanation on the required conditions that articles pass the primary screening to the secondary screening. Please be explicit about that these primary and secondary screenings are used for Japanese population, other population, or both. In addition, for example, the authors mentioned that “The following items were extracted: (1) first author’s name, (2) year of publication, (3) sex, (4) age, (5) exercise mode, and (6) means and distributions of VO2peak and AT (SD, standard error, and confidence interval [CI])”. Please be explicit about that this (and other each procedure) is conducted as the primary screening or secondary screening. Page 7, line 127: VO2peak (or VO2max) is sometimes expressed as / kg lean body mass (LBM). The authors should clearly mention at least once that they used /kg body weight (not LBM) in the Materials and methods section (not only in footnotes of Tables and legends of Figures but also in the Methods section). Page 7, lines 130-131: The reviewer could not understand the meaning of the sentence. Do you mean that the article (ref. 39) reported VO2peak and AT measured by indirect method? It is known that the VO2peak and AT measured by indirectly method are underestimated when they are compared with VO2peak and AT measured by directly method? Page 7, lines 132-134: The authors showed VO2peak and AT data by 10-year age group in Tables 1 and 2. However, they suddenly explain on the categorization of ≤19 years or ≥20 years, before they explain about the 10-year age group categorization first. It is also unclear that these data analyses are applied to Japanese population or other population, or both populations. Data analysis section is poorly written and should be drastically revised to prevent readers’ confusion. Page 7, lines 135-136: The authors mentioned “The slopes and intercepts of the mean and age for each indicator from each study were determined using…”. Is it correct? It should be “The slopes and intercepts of the association of age with VO2peak and AT for each age category (≦19 years, ≧20 years) were determined using…”. Page 8, line 142: Please be explicit about that these are accepted articles and data extraction for Japanese population, or other population than Japanese, or both. Page 10, Table 1: The authors may touch the possible reason why the VO2peak data measured by run are lower than VO2peak data measured by cycle in the age groups of 4-9 and 10-19 in the Materials and methods section or Discussion section. Page 10, Table 1: The percentage of AT in VO2peak is approximately 50% in the age groups of young and middle-aged men (Table 1) and women (Table 2), but the percentage is apparently higher in older men and women (55-61% in Tables 1 and 2). To the reviewer’s knowledge, endurance athletes have a higher percentage of AT in VO2peak (>60%), but not in older people. How do the authors explain this phenomenon? Page 13, lines 216-220: It is unclear that the VO2peak and AT data shown in S2 and S3 figures are measured by cycle, run, or combined with cycle and run. Page 16, lines 273-279: Based on the AT data in the other age groups than 70–89-year group, it seems that the decrease in AT in Japanese population compared with other population (shown in S3 figure) is greater than the decrease in VO2peak in the Japanese population compared with other population (shown in S2 figure). How do the authors explain this interesting phenomenon? Page 18, line 310: The authors stated that “identifying the distribution of aerobic capacity in population may help estimate their health status and develop a health promotion strategy” in Abstract. In addition, they mentioned that “estimated standard values may help set or update more practical reference values for health promotion in the Japanese population” in the conclusion. However, this reviewer could not clearly understand the reason why the estimated standard values may help set or update more practical reference values for health promotion in the Japanese population. Please describe more how the standard values of VO2peak and AT estimated by the present study actually contribute to the development of the reference value of the aerobic capacities for future health promotion, in this Perspectives section or other appropriate sections, more clearly and concretely. Reviewer #2: Line 281. VO2peak/kg is lower in Run than in Cycle for both males and females in their teens. Perhaps this is a discrepancy arising from Tamiya's (1991) higher results for teenagers with Cycle. The author should add a discussion of this result. (No need to re-review.) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Kojiro Ishii ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-15750R1Estimated standard values of aerobic capacity according to sex and age in a Japanese population: a scoping reviewPLOS ONE Dear Dr. Miyachi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yosuke Yamada Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors suitably responded to most of the reviewer’s comments. The reviewer believes that the manuscript has been much improved. However, unfortunately, the authors failed in the revision of the Abstract. An abstract is most important, as is an article title. The authors responded, “However, this information has been only briefly provided to avoid confusion among readers regarding the primary purpose of this meta-analysis, which was to obtain a standard value estimated of aerobic capacity in the Japanese population (Page 2, Lines 20, 23-24).” If so, they should clearly mention that the comparison of the estimated standard values of the Japanese with those of other populations was performed “as a secondary or supplementary analysis” in the Abstract. Why don’t they simply express so? A brief description does not necessarily mean a secondary description, and it is just a lack of sufficient explanation. The authors also mention that “This study aimed to estimate standard values of aerobic capacity (peak oxygen uptake [VO2peak]/kg and anaerobic threshold [AT]/kg) for the Japanese population stratified by sex and age using a meta-analysis and to compare them with those of other populations” in Abstract. This sentence may also confuse readers, because readers may misunderstand that comparing aerobic capacity with those of other populations is one of the two primary analyses. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Estimated standard values of aerobic capacity according to sex and age in a Japanese population: a scoping review PONE-D-23-15750R2 Dear Dr. Miyachi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yosuke Yamada Academic Editor PLOS ONE Additional Editor Comments (optional): Congratulations! Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-23-15750R2 Estimated standard values of aerobic capacity according to sex and age in a Japanese population: a scoping review Dear Dr. Miyachi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yosuke Yamada Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .